Abstract
Abstract Background Infectious Disease (ID) clinicians increasingly collaborate via social media and have adopted Twitter and the hashtag #IDTwitter for community-wide conversation. We investigated clinicians’ use of #IDTwitter for peer consultation, examining both the utility of responses and how frequently discussions risked compromising patient privacy. Methods We reviewed English-language posts on www.twitter.com with the hashtag #IDTwitter over a 6-week period ending August 31st, 2021. We collected posts that we deemed examples of peer consultation, recording the post’s author, topic, engagement produced, and patient information disclosed. Finally, we recorded whether (by consensus) we judged a question meaningfully answered. Results We identified 108 instances of peer consultation; 91 posts (84%) were consultations about a clinical scenario, 17 (16%) included a specific request for medical literature, and seven (6%) included a request for literature interpretation. Twenty-four posts (22%) contained polls, which received a mean 107 (SD 104) votes. We judged 71% of questions meaningfully answered; of these, 68% received responses including explicit justification or reasoning and 35% included citations of supporting literature. Questions were more likely to be meaningfully answered if they included polls (91.7% vs 65.5%; p=0.01). Receipt of a meaningful answer was not predicted by the questioner’s professional role and follower count, the question topic, or the post’s number of likes and shares. A total 28/108 posts (26%) referenced the care of a specific patient, with details shared including gender (74%), age (26%), radiographic or clinical images (7%), and other potentially identifying data (7%). Patients were stated or implied to be currently under the clinician’s care in 70% of cases, and 61 clinicians (92.4%) had their employer listed in their profile or immediately available via internet search. Conclusion ID clinicians’ peer consultations via #IDTwitter appeared frequently useful, particularly when questions were accompanied by polls. However, most participants sharing patient data were readily identifiable, and best practices to limit sharing of nonessential data and safeguard patient privacy are needed. Disclosures Jasmine R. Marcelin, MD, Pfizer (Grant reviewer): Honoraria.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.